loadpatents
Patent applications and USPTO patent grants for Randolph; John T..The latest application filed is for "prodrug modulators of the integrated stress pathway".
Patent | Date |
---|---|
Prodrug Modulators Of The Integrated Stress Pathway App 20220251123 - Martin; Kathleen Ann ;   et al. | 2022-08-11 |
Modulators Of The Integrated Stress Pathway App 20210363136 - Martin; Kathleen Ann ;   et al. | 2021-11-25 |
Prodrug modulators of the integrated stress pathway Grant 11,149,043 - Dart , et al. October 19, 2 | 2021-10-19 |
Prodrug Modulators Of The Integrated Stress Pathway App 20210230195 - Martin; Kathleen Ann ;   et al. | 2021-07-29 |
Modulators Of The Integrated Stress Pathway App 20210169892 - Martin; Kathleen Ann ;   et al. | 2021-06-10 |
Modulators Of The Integrated Stress Pathway App 20200345727 - Martin; Kathleen Ann ;   et al. | 2020-11-05 |
Modulators Of The Integrated Stress Pathway App 20200347043 - Martin; Kathleen Ann ;   et al. | 2020-11-05 |
Glucocorticoid Receptor Agonist And Immunoconjugates Thereof App 20200338208 - McPherson; Michael J. ;   et al. | 2020-10-29 |
Glucocorticoid receptor agonist and immunoconjugates thereof Grant 10,668,167 - McPherson , et al. | 2020-06-02 |
Compositions and Methods for Treating HCV Infection App 20190358214 - Brown; Brian ;   et al. | 2019-11-28 |
Glucocorticoid Receptor Agonist And Immunoconjugates Thereof App 20190262465 - MCPHERSON; Michael J. ;   et al. | 2019-08-29 |
Anti-Viral Compounds App 20190015402 - Bellizzi; Mary E. ;   et al. | 2019-01-17 |
Anti-viral compounds Grant 10,053,474 - Chau , et al. August 21, 2 | 2018-08-21 |
Anti-viral compounds Grant 10,039,754 - Bellizzi , et al. August 7, 2 | 2018-08-07 |
Anti-viral compounds Grant 10,028,937 - Bellizzi , et al. July 24, 2 | 2018-07-24 |
Glucocorticoid Receptor Agonist And Immunoconjugates Thereof App 20180126000 - MCPHERSON; Michael J. ;   et al. | 2018-05-10 |
Anti-Viral Compounds App 20180022763 - Chau; Jaclyn ;   et al. | 2018-01-25 |
Anti-viral compounds Grant 9,676,797 - Chen , et al. June 13, 2 | 2017-06-13 |
Anti-Viral Compounds App 20170157105 - Bellizzi; Mary E. ;   et al. | 2017-06-08 |
Anti-Viral Compounds App 20170157104 - Bellizzi; Mary E. ;   et al. | 2017-06-08 |
Antiviral compounds and uses thereof Grant 9,637,478 - Betebenner , et al. May 2, 2 | 2017-05-02 |
Anti-viral compounds Grant 9,586,978 - Bellizzi , et al. March 7, 2 | 2017-03-07 |
Anti-Viral Compounds App 20170057981 - Chen; Hui-Ju J. ;   et al. | 2017-03-02 |
Antiviral Compounds And Uses Thereof App 20160368905 - Betebenner; David A. ;   et al. | 2016-12-22 |
Agents for treating pain and uses thereof Grant 9,382,258 - Bhatia , et al. July 5, 2 | 2016-07-05 |
Antiviral compounds and uses thereof Grant 9,353,091 - Betebenner , et al. May 31, 2 | 2016-05-31 |
Anti-viral compounds Grant 9,278,922 - Donner , et al. March 8, 2 | 2016-03-08 |
Anti-viral compounds Grant 9,249,138 - Degoey , et al. February 2, 2 | 2016-02-02 |
Anti-infective agents and uses thereof Grant 9,139,536 - Flentge , et al. September 22, 2 | 2015-09-22 |
Agents For Treating Pain And Uses Thereof App 20150225409 - Bhatia; Pramila A. ;   et al. | 2015-08-13 |
Anti-Viral Compounds App 20150218194 - Bellizzi; Mary E. ;   et al. | 2015-08-06 |
Agents for treating pain and uses thereof Grant 9,029,361 - Bhatia , et al. May 12, 2 | 2015-05-12 |
Anti-viral compounds Grant 9,006,387 - Wagner , et al. April 14, 2 | 2015-04-14 |
Anti-Viral Compounds App 20150087618 - Bellizzi; Mary E. ;   et al. | 2015-03-26 |
Anti-infective agents and uses thereof Grant 8,986,740 - Donner , et al. March 24, 2 | 2015-03-24 |
Antiviral Compounds and Uses Thereof App 20150056164 - Betebenner; David A. ;   et al. | 2015-02-26 |
Anti-viral compounds Grant 8,937,150 - DeGoey , et al. January 20, 2 | 2015-01-20 |
Anti-viral compounds Grant 8,921,514 - DeGoey , et al. December 30, 2 | 2014-12-30 |
Anti-viral Compounds App 20140315792 - Wagner; Rolf ;   et al. | 2014-10-23 |
Anti-Infective Agents and Uses Thereof App 20140294766 - Flentge; Charles A. ;   et al. | 2014-10-02 |
Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20140243340 - Klein; Larry L. ;   et al. | 2014-08-28 |
Anti-viral Compounds App 20140213595 - DEGOEY; David A. ;   et al. | 2014-07-31 |
HIV Protease Inhibiting Compounds App 20140194349 - DeGoey; David A. ;   et al. | 2014-07-10 |
Agents For Treating Pain And Uses Thereof App 20140171423 - Bhatia; Pramila A. ;   et al. | 2014-06-19 |
Antiviral compounds and uses thereof Grant 8,748,443 - Betebenner , et al. June 10, 2 | 2014-06-10 |
Compounds that are useful for improving pharmacokinetics Grant 8,741,938 - Kempf , et al. June 3, 2 | 2014-06-03 |
Anti-viral compounds Grant 8,691,938 - DeGoey , et al. April 8, 2 | 2014-04-08 |
Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers Grant 8,669,255 - Li , et al. March 11, 2 | 2014-03-11 |
HIV protease inhibiting compounds Grant 8,653,141 - Flentge , et al. February 18, 2 | 2014-02-18 |
Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers Grant 8,648,074 - Li , et al. February 11, 2 | 2014-02-11 |
Novel Compounds That Are Useful For Improving Pharmacokinetics App 20130317071 - Kempf; Dale J. ;   et al. | 2013-11-28 |
Anti-viral compounds Grant 8,546,405 - DeGoey , et al. October 1, 2 | 2013-10-01 |
Compounds that are useful for improving pharmacokinetics Grant 8,524,753 - Kempf , et al. September 3, 2 | 2013-09-03 |
Anti-infective agents and uses thereof Grant 8,501,238 - Flentge , et al. August 6, 2 | 2013-08-06 |
Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20130131085 - Klein; Larry L. ;   et al. | 2013-05-23 |
SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS App 20130085142 - Li; Tao ;   et al. | 2013-04-04 |
SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINE SULFONAMIDES AS CALCIUM CHANNEL BLOCKERS App 20130085141 - Li; Tao ;   et al. | 2013-04-04 |
Hiv Protease Inhibiting Compounds App 20130023463 - Flentge; Charles A. ;   et al. | 2013-01-24 |
Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20120309762 - Klein; Larry L. ;   et al. | 2012-12-06 |
Anti-infective Agents And Uses Thereof App 20120244119 - Flentge; Charles A. ;   et al. | 2012-09-27 |
Anti-Viral Compounds App 20120220562 - DeGoey; David A ;   et al. | 2012-08-30 |
Anti-infective Agents And Uses Thereof App 20120189580 - Donner; Pamela L. ;   et al. | 2012-07-26 |
Novel Compounds That Are Useful For Improving Pharmacokinetics App 20120184559 - Kempf; Dale J. ;   et al. | 2012-07-19 |
HIV protease inhibiting compounds Grant 8,193,227 - Flentge , et al. June 5, 2 | 2012-06-05 |
Anti-infective agents and uses thereof Grant 8,188,104 - Flengte , et al. May 29, 2 | 2012-05-29 |
Anti-infective agents and uses thereof Grant 8,178,548 - Donner , et al. May 15, 2 | 2012-05-15 |
Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20120083490 - Klein; Larry L. ;   et al. | 2012-04-05 |
Antiviral Compounds And Uses Thereof App 20120082646 - Betebenner; David A. ;   et al. | 2012-04-05 |
Anti-Viral Compounds App 20120004196 - DeGoey; David A. ;   et al. | 2012-01-05 |
Anti-Viral Compounds App 20110207699 - DeGoey; David A. ;   et al. | 2011-08-25 |
Anti-viral Compounds And Methods Of Identifying The Same App 20110137633 - HUTCHINS; CHARLES W. ;   et al. | 2011-06-09 |
Anti-Viral Compounds App 20110092415 - DeGoey; David A. ;   et al. | 2011-04-21 |
HIV protease inhibiting compounds App 20110003827 - Flentge; Charles A. ;   et al. | 2011-01-06 |
Anti-Viral Compounds App 20100317568 - DeGoey; David A. ;   et al. | 2010-12-16 |
HIV protease inhibiting compounds Grant 7,834,043 - DeGoey , et al. November 16, 2 | 2010-11-16 |
Anti-Viral Compounds App 20100267634 - Donner; Pamela L. ;   et al. | 2010-10-21 |
HIV Protease Inhibiting Compounds App 20100249181 - DeGoey; David A. ;   et al. | 2010-09-30 |
Compounds that are useful for improving pharmacokinetics Grant 7,786,153 - Kempf , et al. August 31, 2 | 2010-08-31 |
Anti-Viral Compounds App 20100160355 - DeGoey; David A. ;   et al. | 2010-06-24 |
HIV protease inhibiting compounds Grant 7,696,226 - Randolph , et al. April 13, 2 | 2010-04-13 |
Anti-infective Agents And Uses Thereof App 20090186912 - Flengte; Charles A. ;   et al. | 2009-07-23 |
Anti-infective Agents And Uses Thereof App 20090176784 - Donner; Pamela L. ;   et al. | 2009-07-09 |
Anti-infective agents Grant 7,538,105 - Hutchinson , et al. May 26, 2 | 2009-05-26 |
Anti-infective agents Grant 7,517,876 - Klein , et al. April 14, 2 | 2009-04-14 |
Anti-Infective Agents App 20080193413 - Hutchinson; Douglas K. ;   et al. | 2008-08-14 |
Cytochrome P450 Oxidase Inhibitors and Uses Thereof App 20080161246 - Klein; Larry L. ;   et al. | 2008-07-03 |
Anti-infective agents Grant 7,378,414 - Hutchinson , et al. May 27, 2 | 2008-05-27 |
Anti-infective agents App 20060287300 - Klein; Larry L. ;   et al. | 2006-12-21 |
Novel compounds that are useful for improving pharmacokinetics App 20060199851 - Kempf; Dale J. ;   et al. | 2006-09-07 |
HIV protease inhibiting compounds App 20050159469 - Randolph, John T. ;   et al. | 2005-07-21 |
HIV protease inhibiting compounds App 20050148623 - DeGoey, David A. ;   et al. | 2005-07-07 |
HIV protease inhibiting compounds App 20050131042 - Flentge, Charles A. ;   et al. | 2005-06-16 |
Anti-infective agents App 20050107364 - Hutchinson, Douglas K. ;   et al. | 2005-05-19 |
Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof Grant 6,090,789 - Danishefsky , et al. July 18, 2 | 2000-07-18 |
Macrolide LHRH antagonists Grant 6,020,521 - Randolph , et al. February 1, 2 | 2000-02-01 |
Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof Grant 5,708,163 - Danishefsky , et al. January 13, 1 | 1998-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.